COVID-19–Associated Mold Infection in Critically Ill Patients, Chile

Patients with severe coronavirus disease (COVID-19) may have COVID-19–associated invasive mold infection (CAIMI) develop. We report 16 cases of CAIMI among 146 nonimmunocompromised patients with severe COVID-19 at an academic hospital in Santiago, Chile. These rates correspond to a CAIMI incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabagliati, Ricardo, Rodríguez, Nicolás, Núñez, Carolina, Huete, Alvaro, Bravo, Sebastian, Garcia, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084475/
https://www.ncbi.nlm.nih.gov/pubmed/33760726
http://dx.doi.org/10.3201/eid2705.204412
_version_ 1783686158860943360
author Rabagliati, Ricardo
Rodríguez, Nicolás
Núñez, Carolina
Huete, Alvaro
Bravo, Sebastian
Garcia, Patricia
author_facet Rabagliati, Ricardo
Rodríguez, Nicolás
Núñez, Carolina
Huete, Alvaro
Bravo, Sebastian
Garcia, Patricia
author_sort Rabagliati, Ricardo
collection PubMed
description Patients with severe coronavirus disease (COVID-19) may have COVID-19–associated invasive mold infection (CAIMI) develop. We report 16 cases of CAIMI among 146 nonimmunocompromised patients with severe COVID-19 at an academic hospital in Santiago, Chile. These rates correspond to a CAIMI incidence of 11%; the mortality rate for these patients was 31.2%.
format Online
Article
Text
id pubmed-8084475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-80844752021-05-11 COVID-19–Associated Mold Infection in Critically Ill Patients, Chile Rabagliati, Ricardo Rodríguez, Nicolás Núñez, Carolina Huete, Alvaro Bravo, Sebastian Garcia, Patricia Emerg Infect Dis Dispatch Patients with severe coronavirus disease (COVID-19) may have COVID-19–associated invasive mold infection (CAIMI) develop. We report 16 cases of CAIMI among 146 nonimmunocompromised patients with severe COVID-19 at an academic hospital in Santiago, Chile. These rates correspond to a CAIMI incidence of 11%; the mortality rate for these patients was 31.2%. Centers for Disease Control and Prevention 2021-05 /pmc/articles/PMC8084475/ /pubmed/33760726 http://dx.doi.org/10.3201/eid2705.204412 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Rabagliati, Ricardo
Rodríguez, Nicolás
Núñez, Carolina
Huete, Alvaro
Bravo, Sebastian
Garcia, Patricia
COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title_full COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title_fullStr COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title_full_unstemmed COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title_short COVID-19–Associated Mold Infection in Critically Ill Patients, Chile
title_sort covid-19–associated mold infection in critically ill patients, chile
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084475/
https://www.ncbi.nlm.nih.gov/pubmed/33760726
http://dx.doi.org/10.3201/eid2705.204412
work_keys_str_mv AT rabagliatiricardo covid19associatedmoldinfectionincriticallyillpatientschile
AT rodrigueznicolas covid19associatedmoldinfectionincriticallyillpatientschile
AT nunezcarolina covid19associatedmoldinfectionincriticallyillpatientschile
AT huetealvaro covid19associatedmoldinfectionincriticallyillpatientschile
AT bravosebastian covid19associatedmoldinfectionincriticallyillpatientschile
AT garciapatricia covid19associatedmoldinfectionincriticallyillpatientschile

Ejemplares similares